LBC
ZBH icon

Lowe Brockenbrough & Co’s Zimmer Biomet ZBH Stock Holding History

Lowe Brockenbrough & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
7,521
+561
+8% +$49.2K 0.03% 204
2026
Q1 		$629K Sell
6,960
-147
-2% -$13.5K 0.03% 208
2025
Q4 		$639K Buy
7,107
+976
+16% +$92.5K 0.03% 203
2025
Q3 		$604K Sell
6,131
-30
-0.5% -$2.97K 0.03% 204
2025
Q2 		$562K Buy
6,161
+796
+15% +$77K 0.03% 211
2025
Q1 		$608K Buy
5,365
+12
+0.2% +$1.28K 0.04% 203
2024
Q4 		$567K Sell
5,353
-117
-2% -$12.6K 0.04% 210
2024
Q3 		$592K Buy
5,470
+156
+3% +$17K 0.04% 210
2024
Q2 		$578K Sell
5,314
-334
-6% -$39.4K 0.04% 205
2024
Q1 		$747K Sell
5,648
-595
-10% -$74.3K 0.05% 199
2023
Q4 		$761K Sell
6,243
-25
-0.4% -$2.79K 0.06% 191
2023
Q3 		$705K Sell
6,268
-195
-3% -$24.8K 0.05% 195
2023
Q2 		$943K Sell
6,463
-70
-1% -$9.51K 0.07% 178
2023
Q1 		$846K Sell
6,533
-15
-0.2% -$1.88K 0.07% 186
2022
Q4 		$836K Sell
6,548
-225
-3% -$26.1K 0.07% 184
2022
Q3 		$710K Sell
6,773
-620
-8% -$68K 0.07% 185
2022
Q2 		$778K Sell
7,393
-525
-7% -$62.3K 0.07% 186
2022
Q1 		$1.01M Sell
7,918
-858
-10% -$103K 0.07% 181
2021
Q4 		$1.08M Sell
8,776
-401
-4% -$52.5K 0.08% 172
2021
Q3 		$1.31M Sell
9,177
-175
-2% -$25.7K 0.1% 158
2021
Q2 		$1.46M Sell
9,352
-31
-0.3% -$5.02K 0.13% 131
2021
Q1 		$1.46M Sell
9,383
-145
-2% -$22.5K 0.14% 131
2020
Q4 		$1.43M Buy
9,528
+52
+0.5% +$7.34K 0.15% 124
2020
Q3 		$1.25M Buy
9,476
+61
+0.6% +$7.97K 0.16% 125
2020
Q2 		$1.09M Sell
9,415
-247
-3% -$28.5K 0.15% 129
2020
Q1 		$948K Buy
9,662
+3,147
+48% +$413K 0.16% 126
2019
Q4 		$947K Hold
6,515
– – 0.12% 147
2019
Q3 		$868K Buy
6,515
+773
+13% +$99.9K 0.12% 148
2019
Q2 		$656K Sell
5,742
-31
-0.5% -$3.63K 0.09% 165
2019
Q1 		$716K Buy
+5,773
New +$656K 0.1% 156

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lowe Brockenbrough & Co's ZBH Position: Q2 2026 in Review

Lowe Brockenbrough & Co increased its Zimmer Biomet (ZBH) stake by 8.1% in Q2 2026, buying an estimated $49.2K and bringing the position to 7,521 shares worth $647K. The position accounts for 0.03% of the portfolio, ranked #204.

Lowe Brockenbrough & Co first reported a position in ZBH in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.46M in Q2 2021. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Lowe Brockenbrough & Co held 7,521 shares of Zimmer Biomet worth $647K as of Q2 2026.
  • Lowe Brockenbrough & Co bought 561 Zimmer Biomet shares in Q2 2026, an estimated $49.2K.
  • Zimmer Biomet made up 0.03% of Lowe Brockenbrough & Co's portfolio in Q2 2026, its #204 holding.
  • Lowe Brockenbrough & Co first reported a position in Zimmer Biomet in Q1 2019 and has held it in 30 quarters since.
  • Lowe Brockenbrough & Co's Zimmer Biomet position peaked at $1.46M in Q2 2021.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q2 2026, filed 3 Aug 2026.